Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Trope

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical & Experimental Metastasis|March 10, 2001
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implicationsH S Berner, B Davidson, A Berner, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 29, 2011
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusionsH P Dong, A K Ree Rosnes, A J Bock, et al.
American Journal of Cancer Research|October 12, 2016
Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinomaYaqing Li, Ruixia Huang, Xiaoli Li, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levelsB Davidson, R Reich, A Berner, et al.
Genes, Chromosomes & Cancer|November 1, 2008
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement mapFrancesca Micci, Jörg Weimer, Lisbeth Haugom, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genesFrancesca Micci, Rolf I Skotheim, Lisbeth Haugom, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma TreatmentD J Mathew, S Maurya, J Ho, et al.
Molecular Pharmaceutics|July 19, 2011
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusionsJean-Pierre Gillet, Junbai Wang, Anna Maria Calcagno, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2005
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinomaIe-Ming Shih, Jim Jinn-Chyuan Sheu, Antonio Santillan, et al.
Plos One|December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's CancersThomas E Bartlett, Allison Jones, Ellen L Goode, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical & Experimental Metastasis|March 10, 2001
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implicationsH S Berner, B Davidson, A Berner, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 29, 2011
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusionsH P Dong, A K Ree Rosnes, A J Bock, et al.
American Journal of Cancer Research|October 12, 2016
Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinomaYaqing Li, Ruixia Huang, Xiaoli Li, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levelsB Davidson, R Reich, A Berner, et al.
Genes, Chromosomes & Cancer|November 1, 2008
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement mapFrancesca Micci, Jörg Weimer, Lisbeth Haugom, et al.
Genes, Chromosomes & Cancer|August 21, 2010
Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genesFrancesca Micci, Rolf I Skotheim, Lisbeth Haugom, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Lipidomic Analysis Reveals Drug-Induced Lipoxins in Glaucoma TreatmentD J Mathew, S Maurya, J Ho, et al.
Molecular Pharmaceutics|July 19, 2011
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusionsJean-Pierre Gillet, Junbai Wang, Anna Maria Calcagno, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2005
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinomaIe-Ming Shih, Jim Jinn-Chyuan Sheu, Antonio Santillan, et al.
Plos One|December 3, 2015
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's CancersThomas E Bartlett, Allison Jones, Ellen L Goode, et al.
Pageof 8